Literature DB >> 1352725

Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features.

J Collinge1, J Brown, J Hardy, M Mullan, M N Rossor, H Baker, T J Crow, R Lofthouse, M Poulter, R Ridley.   

Abstract

A large family with autosomal dominant segregation of presenile dementia, and other neurological and behavioural features is described. At various times, family members have carried diagnoses of Alzheimer's disease, Huntington's disease, Parkinson's disease, myoclonic epilepsy, atypical dementia, Pick's disease, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome. Molecular genetic studies have enabled classification of this disease at the molecular level as one of the group of inherited prion diseases. Here we describe the phenotype of inherited prion disease (PrP 144 bp insertion).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352725     DOI: 10.1093/brain/115.3.687

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  45 in total

Review 1.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

Review 2.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

3.  The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease.

Authors:  R J Cordery; K Alner; L Cipolotti; M Ron; A Kennedy; J Collinge; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

Review 4.  De novo mammalian prion synthesis.

Authors:  Federico Benetti; Giuseppe Legname
Journal:  Prion       Date:  2009-10-26       Impact factor: 3.931

5.  Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene.

Authors:  Neeraj Kumar; Bradley F Boeve; Brendon P Boot; Carolyn F Orr; Joseph Duffy; Bryan K Woodruff; Anil K Nair; Jay Ellison; Karen Kuntz; Kejal Kantarci; Clifford R Jack; Barbara F Westmoreland; Julie A Fields; Matthew Baker; Rosa Rademakers; Joseph E Parisi; Dennis W Dickson
Journal:  Arch Neurol       Date:  2011-09

6.  Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.

Authors:  R Chiesa; B Drisaldi; E Quaglio; A Migheli; P Piccardo; B Ghetti; D A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

7.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

8.  Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform.

Authors:  S Lehmann; D A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

10.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.